Elite Pharmaceuticals Inc (ELTP): Within just the next 3 months: LAUN...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

Elite Pharmaceuticals Inc (ELTP)

Reply Private New

Keep Last Read

Replies (3) Next 10 Prev Next

Send PM Follow Ignore

Followers	32
Posts	12459
Boards Moderated	0
Alias Born	08/29/2012

Re: None

Wednesday, 11/14/2018 10:36:36 PM

Wednesday, November 14, 2018 10:36:36 PM

Within just the next 3 months:

LAUNCHES:

1. Elite Pharmaceuticals Launches Phendimetrazine Tartrate Tablets USP, 35 mg with Glenmark Pharma.

2. Elite Pharmaceuticals Launches Isradipine 2.5 mg and 5 mg Capsules with Glenmark Pharma.

3. Elite Pharmaceuticals Launches Trimipramine Maleate 25, 50, 100 mg Tablets with Glenmark Pharma.

APPROVALS:

1. Elite Pharmaceuticals Receives FDA Approval For Generic Norco® Tablets.

2. Elite Pharmaceuticals Receives FDA Approval For Generic Adderall® Tablets.

FILINGS:

1. Elite Pharmaceuticals And SunGen Pharma File ANDA For IR Antibiotic Generic Product.

2. Elite Pharmaceuticals And SunGen Pharma File ANDA For Second IR Antibiotic Generic Product.

PARTNERSHIPS:

1. Elite Pharmaceuticals Announces Strategic Marketing Alliance With SunGen Pharma.

2. Elite Pharmaceuticals Announces Strategic Marketing Alliance For Generic Norco® Tablets.

PATENTS

1. Elite Pharmaceuticals Granted New Patent For Abuse Deterrent Technology.

Keep Last Read

Replies (3) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent ELTP News

Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2024 09:55:26 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/29/2023 07:21:28 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/26/2023 09:20:29 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 09:20:20 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/28/2023 12:05:38 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 11:58:46 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 11:50:54 PM
Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration with ZenaDrone • InvestorsHub NewsWire • 11/16/2023 12:32:07 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/25/2023 08:15:15 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/07/2023 08:05:25 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 09:30:05 PM
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 07/31/2023 08:20:27 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/17/2023 08:15:16 PM
Form 8-K - Current report • Edgar (US Regulatory) • 06/29/2023 09:15:09 PM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 06/29/2023 08:43:45 PM

More ELTP News

InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow